Virt-Advance Prenatal/Postnatal Softgels recalled over manufacturing violations
- Recall date
- December 12, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- VIRTUS PHARMACEUTICALS OPCO II L recalls Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count b…
- Recall number
- D-0238-2017
- FDA classification
- Class III
- Brand / firm
- VIRTUS PHARMACEUTICALS OPCO II L
- Sold / distributed
- Nationwide
Why it was recalled
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made in Canada, NDC 76439-357-90
Get recall alerts
Free email alert whenever VIRTUS PHARMACEUTICALS OPCO II L has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VIRTUS PHARMACEUTICALS OPCO II L